Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
7
7 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- NBI-1065845TAK-653, OsavampatorPhase 35 trials
Neurocrine Biosciences · Major Depressive Disorder
- NBI-1117568Phase 35 trials
Neurocrine Biosciences · Schizophrenia, Bipolar I Disorder, Mania
- NBI-1065890Phase 21 trial
Neurocrine Biosciences · Tardive Dyskinesia
- NBI-1070770Phase 21 trial
Neurocrine Biosciences · Major Depressive Disorder
- NBI-1117567Phase 21 trial
Neurocrine Biosciences · Alzheimer's Disease
- NBI-1117570Phase 21 trial
Neurocrine Biosciences · Schizophrenia
- NBIP-01435Phase 21 trial
Neurocrine Biosciences · Congenital Adrenal Hyperplasia
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.